Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Balversa is a novel targeted anti-cancer drug that inhibits the FGFR signaling p···【more】
Release date：2024-08-26Recommended：350
Balversais an oral, targeted anti-cancer drug that specifically inhibits the FGF···【more】
Release date：2024-08-26Recommended：440
Balversais an oral anticancer drug targeting FGFR mutations for the treatment of···【more】
Release date：2024-08-26Recommended：411
Balversais a new oral anti-cancer drug targeting FGFR, which is specially design···【more】
Release date：2024-08-26Recommended：385
Balversais an oral tyrosine kinase inhibitor for the treatment of non-small cell···【more】
Release date：2024-08-26Recommended：355
Alpelisib has demonstrated a unique efficacy against PIK3CA mutations in HR/HER2···【more】
Release date：2024-08-23Recommended：408
Patients with HR/HER2- advanced breast cancer harboring PIK3CA mutations were si···【more】
Release date：2024-08-23Recommended：547
By specifically inhibiting PIK3CA mutations, Apelis provides a novel therapeutic···【more】
Release date：2024-08-23Recommended：488
Alpelisib fills a gap in the treatment of HR/HER2- breast cancer, particularly i···【more】
Release date：2024-08-23Recommended：442
For patients with advanced HR/HER2- breast cancer, the combination of Alpelisib ···【more】
Release date：2024-08-23Recommended：405
As a PIK3CA inhibitor, Alpelisib works synergistically with fulvestrant to signi···【more】
Release date：2024-08-23Recommended：551
Alpelisib effectively inhibits the proliferation of HR/HER2- breast cancer cells···【more】
Release date：2024-08-23Recommended：532
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
